During monoclonal antibody (mAb) production, variability during cell culturing can compromise bioseparation efficiency and, therefore, therapeutic efficacy. In a recent paper, Scottish researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback